Molecular Partners Ag (MOLN) Return on Equity (2022 - 2025)

Historic Return on Equity for Molecular Partners Ag (MOLN) over the last 4 years, with Q3 2025 value amounting to 121199.71%.

  • Molecular Partners Ag's Return on Equity fell 1211997100.0% to 121199.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 121199.71%, marking a year-over-year decrease of 1211997100.0%. This contributed to the annual value of 341.38% for FY2024, which is 259100.0% down from last year.
  • Latest data reveals that Molecular Partners Ag reported Return on Equity of 121199.71% as of Q3 2025, which was down 1211997100.0% from 95.46% recorded in Q2 2025.
  • Molecular Partners Ag's Return on Equity's 5-year high stood at 750333.17% during Q1 2022, with a 5-year trough of 121199.71% in Q3 2025.
  • In the last 4 years, Molecular Partners Ag's Return on Equity had a median value of 0.0% in 2024 and averaged 76147.13%.
  • Its Return on Equity has fluctuated over the past 5 years, first crashed by 2000000000bps in 2023, then soared by 776215900bps in 2024.
  • Quarter analysis of 4 years shows Molecular Partners Ag's Return on Equity stood at 655377.79% in 2022, then plummeted by -112bps to 77564.1% in 2023, then surged by 100bps to 57.48% in 2024, then plummeted by -210939bps to 121199.71% in 2025.
  • Its Return on Equity was 121199.71% in Q3 2025, compared to 95.46% in Q2 2025 and 60.78% in Q1 2025.